U.S. markets open in 4 hours 47 minutes

Enzo Biochem, Inc. (ENZ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.0400+0.0500 (+1.67%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close2.9900
Open2.9900
Bid0.0000 x 1400
Ask0.0000 x 2900
Day's Range2.9000 - 3.0600
52 Week Range1.8000 - 4.8500
Volume487,323
Avg. Volume349,830
Market Cap147.354M
Beta (5Y Monthly)0.90
PE Ratio (TTM)112.59
EPS (TTM)0.0270
Earnings DateJun 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-26% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
    GlobeNewswire

    Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel

    Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel. COVID-19 tests can be scheduled online and are available at Enzo’s patient service center locations throughout New York and New Jersey with no waiting and rapid results. NEW YORK, NY, June 15, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences

  • Enzo Biochem Reports Third Quarter Fiscal 2021 Results
    GlobeNewswire

    Enzo Biochem Reports Third Quarter Fiscal 2021 Results

    Total third quarter revenue of $32.8 million, a record quarterly high, increased 94% year-over-year Consolidated quarterly gross margin was 49% versus 26% in the previous year period, confirming Enzo’s vertically integrated approach can continue to drive healthy margins in a post pandemic environmentThird consecutive quarter of positive earnings and EPS for the Company Adjusted quarterly EBITDA of $2.7 million and year to date adjusted EBITDA of $8.2 millionEPS amounted to $0.04 per share, compa

  • Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9
    GlobeNewswire

    Enzo Biochem to Report Third Quarter 2021 Financial Results on Wednesday, June 9

    Conference Call and Webcast Scheduled for June 9, 2021, 4:30 pm ETNEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results on Wednesday, June 9, 2021, after the market close. The announcement will be followed by a live audio webcast and conference call at 4:30 pm Eastern Time. Wednesday, June 9th @ 4:30pm ETDomestic: 877-407-0792International: 201-689-8263